{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:13:13Z","timestamp":1777551193536,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1C1B1008004"],"award-info":[{"award-number":["2017R1C1B1008004"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A3B1052328"],"award-info":[{"award-number":["NRF-2018R1A3B1052328"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bbrc.2020.01.073","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T18:09:27Z","timestamp":1579802967000},"page":"224-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interaction between IDH1 WT and calmodulin and its implications for glioblastoma cell growth and migration"],"prefix":"10.1016","volume":"524","author":[{"given":"Sunmi","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-4712","authenticated-orcid":false,"given":"Hyuk Nam","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0291-9542","authenticated-orcid":false,"given":"Soeun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunghyouk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.01.073_bib1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.01.073_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1 alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.01.073_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.01.073_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","article-title":"Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation","volume":"483","author":"Koivunen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.01.073_bib5","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1231677","article-title":"(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible","volume":"339","author":"Losman","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.01.073_bib6","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1101\/gad.198200.112","article-title":"D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function","volume":"26","author":"Sasaki","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2020.01.073_bib7","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.01.073_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.01.073_bib9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/0008-5472.CAN-12-2852","article-title":"Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas","volume":"73","author":"Jin","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2020.01.073_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41419-017-0253-7","article-title":"The interactome and spatial redistribution feature of Ca2+ receptor protein calmodulin reveals a novel role in invadopodia-mediated invasion","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2020.01.073_bib11","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1074\/jbc.M109.097675","article-title":"Molecular interaction and functional regulation of ClC-3 by Ca2+\/calmodulin-dependent protein kinase II (CaMKII) in human malignant glioma","volume":"285","author":"Sontheimer","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.01.073_bib12","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3892\/or.2013.2777","article-title":"Regulation of ASIC1 by Ca2+\/calmodulin-dependent protein kinase II in human glioblastoma multiforme","volume":"30","author":"Sun","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2020.01.073_bib13","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1128\/MCB.21.21.7345-7354.2001","article-title":"Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling","volume":"21","author":"Villalonga","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2020.01.073_bib14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.cell.2015.10.041","article-title":"K-ras promotes tumorigenicity through suppression of non-canonical wnt signaling","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.01.073_bib15","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-05-1173","article-title":"Essential role for Ras signaling in glioblastoma maintenance","volume":"65","author":"HolmenandB","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2020.01.073_bib16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1158\/1535-7163.MCT-10-1139","article-title":"CBP501-calmodulin binding contributes to sensitizing tumor cells to cisplatin and bleomycin","volume":"10","author":"Mine","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2020.01.073_bib17","doi-asserted-by":"crossref","first-page":"74006","DOI":"10.18632\/oncotarget.18598","article-title":"CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding","volume":"8","author":"Saito","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2020.01.073_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1535-7163.MCT-16-0169-T","article-title":"Trifluoperazine, a well-known antipsychotic, inhibits glioblastoma invasion by binding to calmodulin and disinhibiting calcium release channel IP3R","volume":"16","author":"Kang","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2020.01.073_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/psc.837","article-title":"Recombinant preparation and characterization of interactions for a calmodulin-binding chromogranin A peptide and calmodulin","volume":"13","author":"Kang","year":"2007","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.bbrc.2020.01.073_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/jnc.12950","article-title":"Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism","volume":"132","author":"Wen","year":"2015","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2020.01.073_bib21","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1093\/nar\/gkg584","article-title":"Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs","volume":"31","author":"Obenauer","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2020.01.073_bib22","first-page":"18090","article-title":"Identifying the genes regulated by IDH1 via gene-chip in glioma cell U87","volume":"8","author":"Ren","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bbrc.2020.01.073_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nsb1194-795","article-title":"Trifluoperazine-induced conformational change in Ca2+-calmodulin","volume":"1","author":"Vandonselaar","year":"1994","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbrc.2020.01.073_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/mol.114.096941","article-title":"Repurposing the antipsychotic trifluoperazine as an antimetastasis agent","volume":"87","author":"Pulkoski-Gross","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.01.073_bib25","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/ncomms2345","article-title":"Interaction between p68 RNA helicase and Ca2+-calmodulin promotes cell migration and metastasis","volume":"4","author":"Wang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2020.01.073_bib26","doi-asserted-by":"crossref","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","article-title":"Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data","volume":"6","author":"Cheng","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2020.01.073_bib27","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s13277-015-4102-y","article-title":"Anti-tumor activity of phenoxybenzamine hydrochloride on malignant glioma cells","volume":"37","author":"Lin","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bbrc.2020.01.073_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.mehy.2011.01.011","article-title":"Isocitrate dehydrogenase mutations may be a protective mechanism in glioma patients","volume":"76","author":"Zhu","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbrc.2020.01.073_bib29","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/prot.22739","article-title":"Allosteric effects of the antipsychotic drug trifluoperazine on the energetics of calcium binding by calmodulin","volume":"78","author":"Feldkamp","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.bbrc.2020.01.073_bib30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/prot.24781","article-title":"Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulin","volume":"83","author":"Feldkamp","year":"2015","journal-title":"Proteins"},{"key":"10.1016\/j.bbrc.2020.01.073_bib31","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1021\/acs.biochem.7b01287","article-title":"The structural basis of calcium-dependent inactivation of the transient receptor potential vanilloid 5 channel","volume":"57","author":"Bokhovchuk","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2020.01.073_bib32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1096\/fj.10-160705","article-title":"Global dynamic conformational changes in the suppressor domain of IP3 receptor by stepwise binding of the two lobes of calmodulin","volume":"25","author":"Kang","year":"2011","journal-title":"FASEB J."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2030142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2030142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:53:37Z","timestamp":1777398817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2030142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0006291X2030142X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.073","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction between IDH1 WT and calmodulin and its implications for glioblastoma cell growth and migration","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}